AMS Shares Crash 19% as U.S. PE Firm Withdraws Bid — What Leveraged Traders Must Know

Event Summary

Advanced Medical Solutions Group plc (AIM: AMS), a UK-based medical device and wound care company, saw its shares plunge approximately 19% after a U.S. private equity firm withdrew its takeover interest. According to London Stock Exchange regulatory filings and market sources, the PE firm — whose identity has not been officially confirmed — will not proceed with a formal offer. Under the UK Takeover Code, the withdrawing party typically faces a six-month standstill before re-engaging. The share price, which had been trading in a 185.6p–270.5p one-year range per Simply Wall St data, collapsed as the embedded bid premium evaporated.

The selloff fits a classic cross-sector acquisition repricing pattern: market participants who accumulated AMS on takeover speculation are now unwinding positions, compressing the stock back toward standalone fundamental value. According to Simply Wall St, AMS earnings grew ~40% year-over-year and are forecast to grow ~40% per annum, with the stock estimated to trade ~49% below intrinsic fair value — a meaningful cushion for patient investors.

Leverage Impact Analysis

CoinUnited.io offers stock CFDs with up to 2000x leverage, making position sizing discipline critical in sharp gap events like this.

Worked example — Long CFD caught in the drop: A trader holding a 50x long AMS CFD at 247p faces a ~19% adverse move (approximately 47p). At 50x leverage, that 19% move translates to a ~950% loss on margin — a full liquidation scenario for positions without adequate buffer. Even at 10x leverage, the 19% move equates to a 190% margin loss, wiping the position.

Short CFD scenario: Conversely, a trader who anticipated the bid withdrawal and held a 20x short AMS CFD entered at 240p would see approximately 380% return on margin from the ~19% decline — illustrating how M&A acquisition wave events create asymmetric short opportunities when bid premiums unwind.

Key leverage risk: Gap events on AIM-listed small caps can be illiquid at open, meaning slippage can extend losses beyond theoretical calculations. Traders should review our acquisition arbitrage guide for position sizing frameworks around deal-break scenarios.

Monitor open interest and funding rates on CoinUnited.io for real-time confirmation signals before re-entering.

Cross-Market Impact

This is a micro-cap, idiosyncratic event with limited cross-asset spillover. The research confirms no material macro, FX, or commodity impact. However, two narrow read-across channels exist:

1. UK med-tech peers: Companies like Stryker Corporation and other medical device names may see modest sentiment drag if the PE withdrawal signals broader caution on healthcare deal multiples in Europe. This aligns with the M&A acquisition wave theme where PE financing costs are squeezing deal viability.

1. PE deal flow sentiment: If the withdrawal reflects tighter leveraged buyout financing conditions, this marginally supports a risk-off read for other AIM-listed small caps carrying speculative M&A premiums. Our M&A trading guide outlines how deal-break contagion spreads within sectors.

Broad indices (S&P 500, FTSE 100) are unaffected. GBP FX impact is negligible given deal size.

Trading Considerations

Key levels to watch: AMS's one-year low sits at approximately 185.6p (Simply Wall St). If the post-drop price holds above this level, the standalone growth thesis (~40% EPS growth, ~49% discount to fair value per Simply Wall St) may attract value buyers. A break below 185.6p would signal further de-rating beyond the bid premium loss.

The six-month UK Takeover Code standstill on the withdrawing PE firm reduces near-term re-bid probability. Watch for any new RNS filings indicating fresh approaches or a strategic review — these would be the primary re-rating catalysts. Traders should also monitor whether the 2025 EPS consensus (revised down from 0.068 to 0.061 GBP per share) stabilizes or deteriorates further.

Start Trading on CoinUnited.io

Create Your Free Account → — Trade crypto, stocks, forex, indices, and commodities with up to 2000x leverage and zero fees.